Tissue‐specific tumor microenvironments influence responses to immunotherapies-Reference-Cited by-同舟云学术

Tissue‐specific tumor microenvironments influence responses to immunotherapies

Published:2019-01 Issue:11 Volume:8 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin Transl Immunol

Author:

Oliver Amanda J¹²,Davey Ashleigh S¹²,Keam Simon P¹³,Mardiana Sherly¹²,Chan Jack D¹²,Scheidt Bianca¹,Beavis Paul A¹²,House Imran G¹²,Van Audernaerde Jonas RM¹⁴^ORCID,Darcy Phillip K¹²,Kershaw Michael H¹²,Slaney Clare Y¹²

Affiliation:

1. Cancer Immunology Program Peter MacCallum Cancer Centre Melbourne VIC Australia

2. Sir Peter MacCallum Department of Oncology The University of Melbourne Parkville VIC Australia

3. Tumour Suppression Laboratory Peter MacCallum Cancer Centre Melbourne VIC Australia

4. Center for Oncological Research Faculty of Medicine and Health Sciences University of Antwerp Antwerp Belgium

Funder

National Health and Medical Research Council

Cancer Australia

National Breast Cancer Foundation

Susan G. Komen

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1094

Reference64 articles.

1. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

2. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors

3. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

4. Understanding the tumor immune microenvironment (TIME) for effective therapy

5. Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of immune checkpoint inhibitor therapy on bone metastases in non-small-cell lung cancer;Frontiers in Immunology;2024-06-18

2. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer;Journal of Cancer Research and Clinical Oncology;2024-03-11

3. Early T Cell Infiltration Correlates with Anti-CTLA4 Treatment Response in Murine Cancer Models;The Journal of Immunology;2023-11-06

4. Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy;Journal of Nanobiotechnology;2023-07-04

5. Development and Validation of a Prognostic Risk Model for Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors;The Oncologist;2023-04-03